LeukoVAX therapeutic vaccine: Phase I/II crossover trial in 108 patients.

Inflammatics Inc., West Chester, Penn. Product: LeukoVAX therapeutic vaccine Indication: Rheumatoid arthritis Status: Inflammatics began a double-blind, placebo-controlled Phase I/II crossover trial i...